Our Formulation Support Includes
We develop advanced liposomal formulations with the right phospholipid selection, high encapsulation efficiency, controlled particle size, stable zeta potential, improved bioavailability, and targeted delivery. Our unique solvent-free green manufacturing system combines multiple specialised process technologies, ensuring superior product stability, stronger process control, and global regulatory compliance.
End-to-End Development Support
- Strategic lipid selection: Pharmaceutically compatible phospholipids, excipients, stabilisers, coating polymers based on physicochemical compatibility and regulatory compliance.
- Advanced formulation engineering: Optimisation of encapsulation efficiency, particle size distribution, zeta potential, release kinetics, stability profile for superior performance.
- Prototype development feasibility: Scientific laboratory-scale development with technical evaluation, process validation, compatibility studies, and performance benchmarking, establishing viability.
- Dosage form selection strategy: Technical assessment of API characteristics, release requirements, application suitability, and identifying effective and commercially scalable platforms.
Process & Manufacturing
- Critical parameter optimisation: Systematic optimisation of Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) to achieve process robustness and reproducibility.
- Scale-up manufacturing readiness: Seamless transition from laboratory to commercial-scale production through validated strategies, process standardisation, and GMP-compliant preparedness.
- Technology transfer support: End-to-end technical transfer of formulation knowledge, process parameters, manufacturing protocols, and quality specifications for commercial implementation.
- Stability study validation: Comprehensive accelerated and real-time evaluation establishing shelf-life, physicochemical integrity, and packaging compatibility under defined storage conditions.
Regulatory & Commercial Support
- Regulatory documentation preparation: Scientifically structured, GMP-compliant, submission-ready technical dossiers covering formulation development, validation, stability, and global compliance requirements.
- Consumer-ready commercialisation pathway: Complete transformation of liposomal APIs into market-ready finished dosage forms with validated manufacturing and regulatory readiness.
- Quality by design implementation: QbD principles through failure mode analysis, risk prioritisation, multivariable process mapping, and design space establishment.
- Commercial launch support: Strategic commercial execution guidance, including market positioning, technical differentiation, and competitive advantage documentation.
High-Performance Architecture
- Bottom-up vesicle formation: Engineering complex, stable molecular architectures through deep understanding of lipid biophysics, ensuring active sequestration within bilayers.
- Complex active loading mastery: Precise stabilisation of diverse, often conflicting actives into single transparent systems, including acids, growth factors, antioxidants.
- Proprietary mechanical processing: High-speed homogenisation and probe sonication utilising high-shear forces and acoustic cavitation reaching sub-100nm particle ranges.
- Precision dermal partitioning: Engineering delivery systems ensuring >95% active penetration into epidermis/dermis while restricting surface residency to <5%.
Error Rectification Assistance
- Comprehensive failure evaluation: Advanced root cause analysis (RCA), failure mode assessment, CQA investigation identifying instability, low encapsulation, and phase inversion.
- Scientific deviation assessment: Analysis of oxidative degradation, leakage, particle agglomeration, sedimentation, and compromised bioavailability, delivering validated corrective actions.
- Process rectification optimisation: Strategic correction of critical deficiencies through excipient compatibility optimisation, lipid-to-active ratio, and homogenisation kinetics improvement.
- Performance restoration protocols: Zeta potential stability enhancement, spray-drying parameter correction, coating efficiency improvement, and superior process reproducibility.
Risk Assessment & Quality Design
- Strategic QbD implementation: Failure Mode and Effects Analysis (FMEA), risk prioritisation matrices, multivariable process mapping, and establishing proactive control.
- Regulatory compliance assurance: Design space establishment supporting lifecycle management, accelerated commercialisation of high-performance liposomal delivery systems.
- Process control validation: Real-time monitoring protocols, statistical process control implementation, ensuring consistent batch-to-batch quality and manufacturing excellence.
- Corrective action verification: Scientific validation of implemented solutions through analytical testing, stability assessment confirming restored formulation robustness.
Specialised Technical Solutions
- Acid complex stabilisation: Mastery of glycolic acid and salicylic acid inclusion within liposomal systems utilising specific buffering and stabilisers.
- Hair growth innovation: Specialised formulation for targeted hair-nutrient actives using unique solubilisation techniques, overcoming crystallisation and precipitation.
- Colour protection protocols: Stabilisation of L-glutathione, ethyl ascorbic acid, alpha lipoic acid using specialised preservation and intrinsic lipid-phase stabilisers.
- Alcohol-free system development: Achieving transparency through mechanical particle reduction and strategic humectant use rather than harsh solvents.
Nutraceutical & Dietary Supplements
- Precision-engineered nutraceutical formulations: Advanced development designed to enhance bioavailability, gastrointestinal bypass efficiency, intestinal absorption kinetics, and oxidative stability.
- Controlled release performance: Optimisation for vitamins, minerals, antioxidants, amino acids, probiotics, and botanical bioactives, ensuring superior nutrient delivery.
- Long-term product stability: Advanced stabilisation systems ensuring extended shelf-life and consistent potency throughout storage and distribution.
- Consumer format optimisation: Development across oral tablets, capsules, powders, liquids, sachets, meeting diverse consumer preferences and compliance requirements.
Pharmaceutical & Therapeutic Systems
- High-performance pharmaceutical formulations: Development for targeted drug delivery, solubility enhancement, controlled release modulation, pharmacokinetic optimisation, therapeutic efficacy improvement.
- Multi-platform delivery systems: Optimisation across oral, topical, specialised delivery platforms, improving API protection, systemic availability, precision dosing.
- Regulatory compliance integration: Supporting pharmaceutical standards, clinical trial requirements, and regulatory submission documentation throughout the development process.
- Commercial scalability assurance: Validated manufacturing processes supporting large-scale production, quality consistency, and cost-effective commercial manufacturing.
Segment-Specific Formulation Approach
- Sublingual and buccal systems: Specialised mouth sprays (B12, D3, melatonin) offer direct bloodstream access, bypassing first-pass hepatic metabolism.
- Enteric-coated delivery: Precise coating optimisation ensuring 100% stomach protection with complete intestinal release within minutes.
- Effervescent dynamics: Calcium effervescent tablets optimised for a clear solution without residue, providing a premium consumer experience.
- Topical penetration systems: Franz diffusion cell-validated formulations demonstrating superior deep-tissue penetration compared to standard topical applications.
Specialised Format Engineering
- Film-coated tablet stability: Integration of liposomal concentrates into solid dosage, maintaining vesicle integrity through compression and coating processes.
- Chewable and dissolving tablets: Rapid salivary release optimisation with taste-masking technology eliminating metallic mineral tastes.
- Liquid suspension mastery: Zeta potential optimisation, preventing sedimentation while maintaining colloidal stability throughout shelf-life.
- Spray pattern optimisation: Precise droplet size and plume geo
Formulation Challenges We Resolve
Comprehensive control of lipid peroxidation, hydrolytic degradation, phase inversion, precipitation, and vesicle leakage through advanced stabilisation.
Precision improvement of low efficiency, inadequate loading, incomplete entrapment through lipid-to-active ratio balancing and vesicle engineering.
Strategic removal of batch-to-batch inconsistency, spray drying variations, coating non-uniformity through CPP optimisation and analytical control.
Targeted improvement of poor permeability, compromised absorption through particle size modulation and absorption pathway optimisation.
Advanced Technical Troubleshooting
Membrane integrity loss, active release, vesicle rupture corrected through stabiliser optimisation
Low loading, incomplete entrapment, poor retention resolved through ratio balancing and process refinement
Clumping, sedimentation, and size growth was prevented through zeta potential calibration and dispersant selection.
Taste masking failures, texture issues, colour changes addressed through barrier technologyand flavouringg systems
Process variability, equipment limitations, and yield inconsistencies are overcome through systematic parameter optimisation.
Formulation Development & Optimization Readiness
Selection Of Appropriate Liposomal Architecture (Unilamellar, Multilamellar, Nanoliposomes) Based On Active Characteristics, Target Delivery Site, And Commercial Requirements.
Scientific Laboratory-scale Development With Technical Feasibility Evaluation, Compatibility Assessment, Performance Benchmarking, Establishing Formulation Viability And Commercial Potential.
Systematic Optimisation Of Manufacturing Parameters, Equipment Selection, And Quality Control Implementation, Ensuring Reproducible Commercial Production And Regulatory Compliance.
Comprehensive accelerated and real-time stability studies establishing shelf-life specifications, packaging requirements, storage conditions supporting regulatory submissions and market launch.
Why Partner with Lipoedge for Formulation Support
High-precision development specifically tailored for delicate lipid bilayers, ensuring maximum active encapsulation and protection.
Significantly improved absorption of nutrients and pharmaceuticals compared to standard delivery formats through targeted design.
Design of Experiments utilises systematic optimisation of variables, ensuring every product achieves stability and efficacy targets.
Early CQA identification ensures that products such as effervescent tablets and sprays meet predefined standards consistently.
High-speed homogenization, probe sonication, and controlled atmosphere processing, achieving sub-100nm particles with exceptional clarity.
Ready to Elevate Your
Formulation Testing?
Partner with LipoEdge's expert scientific team for end-to-end in vitro analytical support — from study design to regulatory submission.
Frequently Asked Questions
In vitro chemical testing generates release, stability, and bioaccessibility data, enabling informed formulation decisions across nutraceutical, pharmaceutical, and cosmeceutical product development pipelines. This reduces development uncertainty, supports faster optimisation of dosage forms, and strengthens technical confidence before scale-up, validation, and regulatory submission stages.
The INFOGEST model simulates human digestion conditions across salivary, gastric, and intestinal phases, enabling realistic evaluation of liposomal stability and release behaviour. It helps predict oral bioavailability, validate formulation performance under physiological conditions, and support scientifically substantiated claims for product positioning and regulatory documentation.
Dialysis and simulated digestion studies quantify controlled release behaviour, enabling clear differentiation between liposomal systems and conventional formulations in performance-driven markets. This supports claims of sustained delivery, improved absorption, and enhanced functionality, strengthening product positioning across competitive nutraceutical and pharmaceutical segments globally.
LipoEdge provides integrated in vitro testing using validated digestion models, diffusion systems, and antioxidant assays to ensure reliable and reproducible analytical outcomes. It enables clients to generate regulatory-aligned data, optimise formulations effectively, and accelerate product development timelines with strong technical and commercial confidence.
LipoEdge combines formulation understanding with analytical expertise, enabling customised study designs tailored to liposomal, nanosomal, and encapsulated delivery systems across applications. This ensures deeper insight into product behaviour, improved interpretation of results, and stronger alignment between laboratory findings and real-world product performance expectations.